Patents by Inventor David William White

David William White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9805831
    Abstract: There is provided a fuel rod assembly comprising a first component of a zirconium-based material. The first component is in contact with or is located adjacent to a second component of a material different from the zirconium-based material, e.g. a nickel-based or iron-based alloy. A coating is disposed on an outer surface of the first component, which is effective to reduce an electrochemical corrosion potential difference between the first component and the second component relative to an electrochemical corrosion potential difference between the first component and the second component without the coating.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: October 31, 2017
    Assignee: General Electric Company
    Inventors: Young Jin Kim, Dennis Michael Gray, David William White, Yang-Pi Lin, Todd Charles Curtis, Charles Beaty Patterson
  • Publication number: 20160005499
    Abstract: A method of coating a nuclear reactor component includes introducing the nuclear reactor component into a colloidal solution at a first rate to obtain an immersed component. The colloidal solution is a non-crosslinked mixture including a dispersed phase within a dispersion medium. The dispersed phase may include n-type metal oxide particles. The method additionally includes removing the immersed component from the colloidal solution at a second rate to obtain a wet component. The method also includes drying the wet component to obtain a dried component. The method further includes baking the dried component to obtain a coated component. Accordingly, the nuclear reactor component is provided with a protective layer that reduces or prevents the occurrence of corrosion.
    Type: Application
    Filed: July 3, 2014
    Publication date: January 7, 2016
    Applicant: GE NUCLEAR ENERGY
    Inventors: Yang-Pi LIN, Young Jin KIM, David William WHITE, Garrett Scott NAVE, Patricia P. MCCUMBEE
  • Publication number: 20140334592
    Abstract: There is provided a fuel rod assembly comprising a first component of a zirconium-based material. The first component is in contact with or is located adjacent to a second component of a material different from the zirconium-based material, e.g. a nickel-based or iron-based alloy. A coating is disposed on an outer surface of the first component, which is effective to reduce an electrochemical corrosion potential difference between the first component and the second component relative to an electrochemical corrosion potential difference between the first component and the second component without the coating.
    Type: Application
    Filed: July 24, 2014
    Publication date: November 13, 2014
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Young Jin Kim, Dennis Michael Gray, David William White, Yang-Pi Lin, Todd Charles Curtis, Charles Beaty Patterson
  • Patent number: 8792607
    Abstract: There is provided a fuel rod assembly comprising a first component of a zirconium-based material. The first component is in contact with or is located adjacent to a second component of a material different from the zirconium-based material, e.g. a nickel-based or iron-based alloy. A coating is disposed on an outer surface of the first component, which is effective to reduce an electrochemical corrosion potential difference between the first component and the second component relative to an electrochemical corrosion potential difference between the first component and the second component without the coating.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: July 29, 2014
    Assignee: General Electric Company
    Inventors: Young Jin Kim, Dennis Michael Gray, David William White, Yang-Pi Lin, Todd Charles Curtis, Charles Beaty Patterson
  • Patent number: 8116422
    Abstract: A zirconium alloy suitable for forming reactor components that exhibit reduced irradiation growth and improved corrosion resistance during operation of a light water reactor (LWR), for example, a boiling water reactor (BWR). During operation of the reactor, the reactor components will be exposed to a strong, and frequently asymmetrical, radiation fields sufficient to induce or accelerate corrosion of the irradiated alloy surfaces within the reactor core. Reactor components fabricated from the disclosed zirconium alloy will also tend to exhibit an improved tolerance for cold-working during fabrication of the component, thereby simplifying the fabrication of such components by reducing or eliminating subsequent thermal processing, for example, anneals, without unduly degrading the performance of the finished component.
    Type: Grant
    Filed: December 29, 2005
    Date of Patent: February 14, 2012
    Assignee: General Electric Company
    Inventors: Daniel Reese Lutz, Gerald Allen Potts, Yang-Pi Lin, Sheikh Tahir Mahmood, Mark Andrew Dubecky, David William White, John Schardt
  • Publication number: 20120009183
    Abstract: A method for treating acute or chronic pancreatitis in a subject comprises administering to the subject a therapeutically effective amount of an ACE2 inhibitor.
    Type: Application
    Filed: June 28, 2011
    Publication date: January 12, 2012
    Applicant: Ore Pharmaceuticals Inc.
    Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Luz-Maria Guzman
  • Patent number: 7842709
    Abstract: A method for treating an inflammatory disease of the digestive tract, for example inflammatory bowel disease, in a subject comprises administering to the subject a therapeutically effective amount of a compound selected from the group consisting of (S,S)-2- [1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]-ethylamino]-4-methylpentanoic acid and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: September 7, 2007
    Date of Patent: November 30, 2010
    Assignee: Ore Pharmaceuticals Inc.
    Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Dominic Picarella
  • Publication number: 20100091934
    Abstract: There is provided a fuel rod assembly comprising a first component of a zirconium-based material. The first component is in contact with or is located adjacent to a second component of a material different from the zirconium-based material, e.g. a nickel-based or iron-based alloy. A coating is disposed on an outer surface of the first component, which is effective to reduce an electrochemical corrosion potential difference between the first component and the second component relative to an electrochemical corrosion potential difference between the first component and the second component without the coating.
    Type: Application
    Filed: October 14, 2008
    Publication date: April 15, 2010
    Inventors: Young Jin Kim, Dennis Michael Gray, David William White, Yang-Pi Lin, Todd Charles Curtis, Charles Beaty Patterson
  • Publication number: 20090285350
    Abstract: A fuel channel according to example embodiments for a nuclear reactor may have an elongated and hollow body with a multi-layer structure. The multi-layer structure may include a core layer and at least one cladding layer metallurgically-bonded to the core layer. The core layer and the at least one cladding layer may be alloys having different compositions. For instance, the core layer may be significantly more resistant to irradiation growth and/or irradiation creep than the at least one cladding layer, and the at least one cladding layer may have an increased resistance to hydrogen absorption and/or corrosion relative to the core layer. Accordingly, the distortion of the fuel channel may be reduced or prevented, thus reducing or preventing the interference with the movement of the control blade.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 19, 2009
    Inventors: Paul Everett Cantonwine, David William White
  • Publication number: 20090192220
    Abstract: A method for treating a solid tumor in a subject comprises administering to the subject an ACAT inhibitory compound or a prodrug thereof, for example avasimibe, wherein (a) the solid tumor is at least about 2 mm in diameter and (b) the compound or prodrug thereof is administered in an amount that is therapeutically effective, but ineffective to cause unacceptable toxicity to normoxic tissues.
    Type: Application
    Filed: November 17, 2008
    Publication date: July 30, 2009
    Applicant: Ore Pharmaceuticals Inc.
    Inventors: David William White, Jin Shengfang, Robert Mark Coopersmith, Scott Edward Malstrom, Thi T. Nguyen
  • Publication number: 20090186014
    Abstract: A method for treating acute or chronic pancreatitis in a subject comprises administering to the subject a therapeutically effective amount of an ACE2 inhibitor.
    Type: Application
    Filed: October 9, 2008
    Publication date: July 23, 2009
    Applicant: Ore Pharmaceuticals Inc.
    Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Luz-Maria Guzman
  • Publication number: 20090022259
    Abstract: A fuel rod includes a cladding tube with a wear-inhibiting coating. In one embodiment, the coating is made of a metallic powder material that is applied to the exterior surface of the cladding tube using a thermal spray process. In an alternative embodiment, the coating is a composite made of a metallic powder material, and a ceramic powder material or a metal oxide hard phase powder material that is simultaneously applied with the metallic powder material to coat the cladding tube. The coating can be applied to selected areas of the fuel rods where debris tends to fret the fuel rod.
    Type: Application
    Filed: July 20, 2007
    Publication date: January 22, 2009
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Dennis Michael Gray, David William White, Peter Louis Andresen, Young Jin Kim, Yang-Pi Lin, Todd Charles Curtis, Charles Beaty Patterson
  • Publication number: 20090012052
    Abstract: A method for selecting a female breast cancer patient for AT1 receptor antagonist therapy comprises (a) determining whether the cancer comprises a tumor that is ER+ and/or PR+; and (b) selecting the patient for AT1 receptor antagonist therapy only if the cancer is determined to comprise an ER+ and/or PR+ tumor. A method for treating breast cancer in a female patient further comprises (c) administering to the patient, if so selected, an AT1 receptor antagonist according to a regimen effective to reduce growth, invasiveness and/or metastasis of the tumor.
    Type: Application
    Filed: April 9, 2008
    Publication date: January 8, 2009
    Applicant: Ore Pharmaceuticals Inc.
    Inventors: Robert Mark Coopersmith, David William White, Shengfang Jin, Denzyl Fernandes, Xuena Lin
  • Publication number: 20080234345
    Abstract: A method is provided for reducing or alleviating inflammation or a pathological process associated therewith or secondary thereto in a subject having an inflammatory disease of the digestive tract. The method comprises administering to the subject an anti-inflammatorily effective amount of an ACE2 inhibitor.
    Type: Application
    Filed: September 7, 2007
    Publication date: September 25, 2008
    Applicant: Gene Logic Inc.
    Inventors: Louis Anthony Tartaglia, Thomas Michael Barnes, Robert Mark Coopersmith, Scott Edward Malstrom, David William White, Dominic Picarella
  • Publication number: 20080132474
    Abstract: A method for selecting a female breast cancer patient for AT1 receptor antagonist therapy comprises (a) determining whether the cancer comprises a tumor that is ER+ and/or PR+; and (b) selecting the patient for AT1 receptor antagonist therapy only if the cancer is determined to comprise an ER+ and/or PR+ tumor. A method for treating breast cancer in a female patient further comprises (c) administering to the patient, if so selected, an AT1 receptor antagonist according to a regimen effective to reduce growth, invasiveness and/or metastasis of the tumor.
    Type: Application
    Filed: November 6, 2007
    Publication date: June 5, 2008
    Applicant: Gene Logic Inc.
    Inventors: Robert Mark Coopersmith, David William White, Shengfang Jin, Denzyl Fernandes, Xuena Lin